Medicare Enrolled

Dr. Ulla Laakso, MD

Psychiatry · New York, NY
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
910 PARK AVE, New York, NY 10021
2125173900
In practice since 2006 (19 years)
NPI: 1598841371 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Laakso from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Laakso? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Laakso

Dr. Ulla Laakso is a psychiatry specialist in New York, NY, with 19 years of NPI registration. Based on federal Medicare data, Dr. Laakso performed 1,417 Medicare services across 335 unique beneficiaries.

Between the years covered by Open Payments, Dr. Laakso received a total of $825,211 from 41 pharmaceutical and/or device companies across 3202 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in psychiatry. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Laakso is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 8% volume in NY $825,211 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,417
Medicare services
Top 8% in NY for psychiatry
335
Unique beneficiaries
$95
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~75 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
942 $109 $219
Telephone medical discussion, 11-20 minutes
A phone conversation with a physician lasting between 11 and 20 minutes.
228 $52 $150
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
140 $71 $159
Telephone medical discussion, 21-30 minutes
A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone.
81 $78 $200
Psychiatric diagnostic evaluation
A clinical assessment conducted by a psychiatrist to evaluate a patient's mental health status and determine a diagnosis.
26 $130 $310
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$825,211
Total received (2018-2024)
Avg $117,887/year across 7 years
Top 0% in NY for psychiatry
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
41
Companies
3,202
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$749,340 (90.8%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$56,711 (6.9%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$19,160 (2.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$168,067
2023
$172,308
2022
$111,121
2021
$92,445
2020
$68,125
2019
$96,388
2018
$116,757

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Otsuka America Pharmaceutical, Inc.
$37,388
Vanda Pharmaceuticals Inc.
$27,318
Alkermes, Inc.
$23,740
Axsome Therapeutics, Inc.
$17,755
Supernus Pharmaceuticals, Inc.
$16,845
Teva Pharmaceuticals USA, Inc.
$15,349
E.R. Squibb & Sons, L.L.C.
$9,050
ABBVIE INC.
$8,676
Tris Pharma Inc
$7,728
IDORSIA PHARMACEUTICALS US INC
$1,914
Lundbeck LLC
$809
Bausch Health US, LLC
$520
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$452
Neos Therapeutics, LP
$215
IRONSHORE PHARMACEUTICALS INC.
$131
Neurocrine Biosciences, Inc.
$79
Noven Therapeutics, LLC
$40
Corium, LLC
$36
Vertical Pharmaceuticals, LLC
$24
Top 3 companies account for 52.6% of 2024 payments
All-time payments by company (2018-2024) ›
Alkermes, Inc.
$214,059
Otsuka America Pharmaceutical, Inc.
$208,508
Teva Pharmaceuticals USA, Inc.
$83,155
ABBVIE INC.
$49,143
Axsome Therapeutics, Inc.
$33,679
Vanda Pharmaceuticals Inc.
$29,281
Neurocrine Biosciences, Inc.
$25,832
Supernus Pharmaceuticals, Inc.
$25,821
AbbVie Inc.
$21,958
Allergan, Inc.
$17,258
Sunovion Pharmaceuticals Inc.
$17,015
IDORSIA PHARMACEUTICALS US INC
$16,782
Validus Pharmaceuticals LLC
$15,715
Tris Pharma Inc
$14,544
Allergan Inc.
$12,857
Neos Therapeutics, LP
$11,370
E.R. Squibb & Sons, L.L.C.
$9,050
Lundbeck LLC
$4,073
Merck Sharp & Dohme Corporation
$3,860
Corium, LLC
$2,423
Neurocrine BioSciences, Inc.
$1,700
Bausch Health US, LLC
$1,535
ITI, Inc.
$1,283
Takeda Pharmaceuticals U.S.A., Inc.
$1,092
Shire North American Group Inc
$512
Janssen Pharmaceuticals, Inc
$466
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$452
Eisai Inc.
$405
Avanir Pharmaceuticals, Inc.
$316
Noven Therapeutics, LLC
$155
Adlon Therapeutics L.P.
$153
IRONSHORE PHARMACEUTICALS INC.
$131
Ironshore Pharmaceuticals Inc.
$130
ARBOR PHARMACEUTICALS, INC.
$101
Merck Sharp & Dohme LLC
$95
ACADIA Pharmaceuticals Inc
$88
Vertical Pharmaceuticals, LLC
$76
Aytu BioPharma, Inc.
$58
Almatica Pharma LLC
$33
Harmony Biosciences LLC
$32
Arbor Pharmaceuticals, Inc.
$16
Top 3 companies account for 61.3% of all-time payments
Associated products mentioned in payments ›
ABILIFY ASIMTUFII · ABILIFY MAINTENA · ABILIFY MYCITE · ADHANSIA XR · AJOVY · APLENZIN · ARISTADA · AUSTEDO · AZSTARYS · Adzenys XR-ODT · Aristada 441 mg · Austedo XR · Auvelity · Azstarys · BELSOMRA · BRINTELLIX · CAPLYTA · COBENFY · COTEMPLA XR-ODT · Dayvigo · Dyanavel XR · Equetro · Evekeo · Evekeo ODT · FANAPT · Fanapt · HETLIOZ · Hetlioz · Horizant · INGREZZA · INVEGA SUSTENNA · INVEGA TRINZA · JORNAY PM · Jornay PM 20mg capsules (Bottle of 100) · LATUDA · LYBALVI · MYDAYIS · NUEDEXTA · NUPLAZID · Nuedexta · QELBREE · QUVIVIQ · Qelbree · Quillichew ER · Quillivant · RELEXXII · REXULTI · Relexxii · SECUADO · SERTRALINE HCL · SPRAVATO · TRINTELLIX · Trintellix · UBRELVY · UZEDY · VIIBRYD · VIVITROL · VRAYLAR · VYVANSE · Vivitrol 380 mg · Vyvanse · WAKIX · WELLBUTRIN · WELLBUTRIN XL · Xelstrym
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (91%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in psychiatry and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 0% for psychiatry in NY.

Looking for a psychiatry specialist in New York?
Compare psychiatrists in the New York area by procedure volume, costs, and industry payment transparency.
Browse psychiatrists nearby

Geographic Context

Psychiatrists within 10 mi
5,032
Per 100K population
309.1
County median income
$104,553
Nearest hospital
HOSPITAL FOR SPECIAL SURGERY
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Laakso is a clinical cardiology specialist, with above-average Medicare volume (top 8% in NY), with speaking/promotional industry engagement in the top 0% of NY peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Laakso experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Laakso performed 942 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Laakso receive payments from pharmaceutical companies?
Yes. Dr. Laakso received a total of $825,211 from 41 companies across 3,202 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Laakso's costs compare to other psychiatrists in New York?
Dr. Laakso's average Medicare payment per service is $95. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Laakso) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →